Hizentra

Indicated For

Primary Immunodeficiency (PI), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

About This Medication

# CSL Behring Patient Assistance Program Patient Guide: How to Get Hizentra (immune globulin subcutaneous (human) 20%) at Low or No Cost Hizentra is a vital subcutaneous immune globulin therapy used to treat primary immunodeficiency diseases (PIDD) by boosting your immune system with antibodies to help prevent infections. The **CSL Behring Patient Assistance Program** offers this medication at low or no cost to qualified **uninsured or underinsured patients** who meet income and residency requirements, ensuring access to essential treatment without financial burden.[1][3][9] ## About Hizentra **Hizentra** is a 20% solution of immune globulin derived from human plasma, administered subcutaneously (under the skin) at home or in a clinical setting. Unlike intravenous options, it allows flexible weekly or bi-weekly dosing, reducing treatment time and lifestyle disruption. It's FDA-approved for adults and children 2 years and older with PIDD, helping replace missing antibodies to fight infections. Common side effects include injection site reactions, headache, and fatigue—always consult your doctor for personalized advice.[1] This program is part of CSL Behring's commitment to patient support, including assurance programs for insurance lapses and nurse education for self-administration.[1][6] ## Who Qualifies? The program targets **uninsured or underinsured patients** in the US (including Puerto Rico) who cannot afford their prescribed CSL Behring therapies like Hizentra. You must be a US resident, have a valid prescription, and provide proof of financial need. Patients on government programs like Medicare, Medicaid, TRICARE, or SCHIP typically do not qualify for co-pay aid but should check for patient assistance specifics—contact the program for Medicare Part D details.[2][3][10] No strict federal poverty level (FPL) percentage is specified; eligibility is based on individual circumstances, income documentation, and medical necessity.[3] ## Income Eligibility Breakdown Income thresholds are not fixed by household size or FPL percentage in available details. Instead, qualification relies on submitted proof of income showing inability to afford therapy. Here's a general guide based on program needs-based approach: | Household Size | Typical Income Consideration | Notes | |--------------- |---------------------------- |-------| | Individual | Assessed case-by-case (e.g., W2, pay stubs) | Must demonstrate financial hardship [3] | | Couple | Assessed case-by-case | No fixed FPL limit specified [1] | | Family of 3 | Assessed case-by-case | Income docs required for all [3] | | Family of 4+ | Assessed case-by-case | Focus on uninsured/underinsured status [10] | **Notes:** Provide recent income proof like W2s, pay stubs, or notarized letters. The program evaluates holistically—no automatic cutoffs listed.[3] ## Insurance Requirements - **Uninsured patients** qualify directly with proof of no coverage. - **Underinsured patients** (e.g., high copays/deductibles) may qualify if insurance doesn't fully cover Hizentra. - **Exclusions:** Government-funded insurance (Medicare, Medicaid, etc.) patients are often ineligible; contact for exceptions.[2][3][10] - If you have commercial insurance but face a lapse, explore CSL Behring Assurance for bridge coverage.[1][6] ## Step-by-Step Application Process 1. **Call to Start:** Contact (877) 355-4447 Monday-Friday to speak with a case manager. They'll preliminarily screen eligibility and send a **Patient Assistance Qualification Form** via email or fax.[3] 2. **Gather Documents:** Prepare: - **Proof of residency** (e.g., utility bill, driver's license). - **Proof of income** (W2, pay stubs, notarized letter). - **Prescription** for brand-name Hizentra. - **Insurance status documentation** (letter explaining no/underinsurance, prior authorization denials if applicable). - **Physician letter** with your name, address, DOB, SSN, diagnosis, insurance synopsis.[3] 3. **Complete Forms:** Patient and physician complete the form together. Prescriber fills Sections A (info) and B (authorization).[5] 4. **Submit:** Return via fax/email as instructed. No online portal specified—phone-led process.[3] 5. **Approval Wait:** Varies; quick access for eligible patients, up to 3-month supply initially.[3] **Application Method:** Multiple (phone, fax/email forms).[3] ## Timeline and Delivery - **Processing Time:** Not fixed; case managers notify of status after verification. Approvals can be rapid for urgent needs.[3][6] - **Delivery:** Medication shipped overnight **to your home, physician's office, specialty pharmacy, or hospital**—your choice.[3] - **Supply Duration:** Varies by circumstances; often 3 months initially, with **reauthorization required** for refills.[3] Refills involve contacting the program; no routine forms unless need changes. ## Alternatives if Denied - **Appeal:** Provide additional documentation or updated income proof. - **CSL Behring Assurance:** For commercial insurance lapses (call 866-415-2164).[6] - **Co-Pay Programs:** If commercially insured (up to $12,000/year, exclusions apply).[2] - **Other Resources:** State programs, NeedyMeds, PAN Foundation, or generic/biosimilar immune globulins (none listed for Hizentra).[4] - **Clinical Nurse Education:** Free support for Hizentra administration.[1] ## Important Disclaimer This guide is for informational purposes based on publicly available program details as of latest updates. Eligibility, terms, and availability can change—**always verify directly with CSL Behring at (877) 355-4447**. CSL Behring reserves the right to modify/discontinue the program without notice. Not affiliated with government programs. Consult your healthcare provider before starting/stopping Hizentra. Word count: 1028.

Program information last verified: March 30, 2026